Maruti Suzuki Reports 26% Rise In Production For September

New Delhi: Maruti Suzuki India Ltd, India's largest carmaker, has informed that its production rose 26 per cent year-on-year in September 2025, supported by strong market demand and higher vehicle dispatches.

The company manufactured 2,01,915 units across its plants during the month, compared with 1,59,743 units in September 2024, according to a regulatory filing.

Utility vehicles such as the Brezza, Ertiga and Fronx registered a 27 per cent annual growth in production, touching 79,496 units versus 62,752 units a year earlier. Production of the Eeco van also rose to 13,201 units from 11,702 units, while the Super Carry Light Commercial Vehicle (LCV) grew to 3,599 units from 3,034 units in the same period.

Production of the Alto and S-Presso stood at 12,318 units, nearly flat against 12,155 units a year earlier. Compact segment models including the Baleno, Celerio, Dzire and Swift saw a sharp rise, with output climbing to 93,301 units from 68,413 units in the year-ago period.

As per the company, no units of the mid-size sedan Ciaz were produced in September, compared with 1,687 units in the same month last year. Earlier this week, the automaker reported that its total sales in September increased 3 per cent year-on-year to 1,89,665 units.

From now on, the Indian automobile industry is heading into the second half of FY26 with cautious optimism, as festive stocking, reduction in GST rates, and income tax relief are expected to boost consumer demand, Axis Securities said in its recent report.

According to the brokerage firm, September sales data reflected a mixed trend with strong growth in two-wheelers, three-wheelers, commercial vehicles, and tractors, even as passenger vehicle volumes slipped on a Year-on-Year (YoY) basis.

"We remain cautiously optimistic for H2FY26, expecting high single-digit growth in PVs and steady demand in CVs, supported by festive demand, GST cuts, rural recovery, and new model launches," the domestic brokerage firms said. Tractor sales are also expected to remain buoyant, aided by improved kharif harvest and reservoir conditions, the domestic brokerage firm said.

Comments

Brain-Damaging Tapeworm Infections on the Rise in Mumbai This Monsoon | Seizures and Headaches Among Key Symptoms

Brain-Damaging Tapeworm Infections on the Rise in Mumbai This Monsoon | Seizures and Headaches Among Key Symptoms 🧠 A Hidden Parasite Threat: Tapeworm Infections Damaging Brains in Monsoon-Hit Mumbai As the rainy season drenches the city of Mumbai, a far more insidious danger lurks beneath the puddles and clogged drains: brain-damaging tapeworm infections. A rising number of people are being hospitalized with neurological symptoms such as seizures, persistent headaches, and even confusion—and the cause is far more dangerous than many realize. Medical experts have traced this concerning outbreak to neurocysticercosis , a parasitic infection caused by the larval form of the pork tapeworm, Taenia solium . With Mumbai's sanitation system overwhelmed by monsoon rains, the risk of transmission has significantly escalated, making this an urgent public health concern that is now catching global attention. 🚨 What Is Neurocysticercosis? Neurocysticercosis is an infection of the cen...

🇮🇳 चीन पीछे छूटा! भारत बनी दुनिया की तीसरी सबसे ताकतवर एयरफोर्स – जानें पूरी रिपोर्ट

🇮🇳 चीन पीछे छूटा… अमेरिका-रूस के बाद भारत के पास है दुनिया की सबसे ताकतवर एयरफोर्स, पाकिस्तान टॉप-10 में भी नहीं 🌍 WDMMA की रिपोर्ट में भारत को तीसरा स्थान विश्व की वायु सेनाओं की ताकत का आकलन करने वाली संस्था World Directory of Modern Military Aircraft (WDMMA) ने हाल ही में अपनी 2025 की रिपोर्ट जारी की है। इस रिपोर्ट के अनुसार — पहले स्थान पर अमेरिका , दूसरे पर रूस , और तीसरे स्थान पर भारत की वायुसेना (Indian Air Force) है। चीन, जिसे अब तक भारत से आगे माना जाता था, इस बार चौथे स्थान पर खिसक गया है। रिपोर्ट में बताया गया है कि भारतीय वायुसेना (IAF) का TruVal Rating स्कोर 69.4 रहा, जबकि चीन की PLAAF (People’s Liberation Army Air Force) को 63.8 अंक मिले। 🇨🇳 चीनी विशेषज्ञ ने दी सफाई – “कागज़ी ताकत असली नहीं होती” इस रैंकिंग के बाद चीन में हलचल मच गई। चीनी सैन्य मामलों के विशेषज्ञ झांग जुनशे (Zhang Junshe) ने बयान दिया कि — “सिर्फ कागज़ों पर दिखने वाली ताकत असली क्षमता नहीं होती, असली ताकत युद्धक्षेत्र में प्रदर्शन से साबित होती है।” उनका कहना है ...

India Tightens Drug Price Oversight in 2025: NPPA Targets Overpriced Non-Scheduled Medicines | Pharma Firms Under Scanner

🎯 Government Tightens Oversight of Non‑Scheduled Drugs 1. What Changed? Non‑scheduled drugs —those not under DPCO price caps—have historically allowed up to 10% annual price increase by manufacturers ( The Indian Express ). Although not regulated like essential or life‑saving medicines, the National Pharmaceutical Pricing Authority (NPPA) can still monitor these prices and intervene if firms exceed that 10% limit or demonstrate unreasonable hikes ( GLI ). 2. Why the Policy Tightening? New scrutiny has emerged after the Parliamentary Standing Committee flagged 307 violations as of March 6, 2025, involving non‑scheduled drug manufacturers who exceeded the legally permissible increase on maximum retail price (MRP) ( Medical Dialogues ). This prompted the government to clarify and reinforce enforcement mechanisms , scrutinizing pricing behavior of non-scheduled drug companies more closely. 🚨 What Enforcement Looks Like NPPA now tracks MRP trajectories of n...

Globalnews

Search This Blog